OA01.04 First-Line Nivolumab + Ipilimumab + Chemotherapy in Metastatic NSCLC: CheckMate 9LA 3-Year Update
| Autor: | Carbone, D.P., Paz-Ares, L.G., Ciuleanu, T.E., Cobo-Dols, M., Bennouna, J., Cheng, Y., Mizutani, H., Lingua, A., Reyes, F., Reinmuth, N., Menezes, J., Jassem, J., Protsenko, S., Feeney, K., de la Mora Jimenez, E., Lu, S., John, T., Zhang, X., Hu, N., Reck, M. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2023 18(3) Supplement:e2-e2 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|